Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types
(Q68805101)
scientific article published on 01 October 1986
scientific article published on 01 October 1986
Language: